Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
International Society for Heart and Lung Transplantation 25th Anniversary Meeting
April 6 - 9, 2005, Philadelphia, Pennsylvania

This activity was developed in collaboration with the International Society for Heart and Lung Transplantation.


Topic Overviews
Highlights of the International Society for Heart and Lung Transplantation Twenty-Fifth Anniversary Meeting and Scientific Sessions CME
Physicians - up to 0.75 hour(s) of AMA PRA category 1 credit
Proliferation Signal Inhibition In Heart and Lung Transplantation
Howard Eisen, MD
Primary Graft Dysfunction After Lung Transplantation
Steven Nathan, MD
Conference News
Assist Device May Help Bridge Patients to Lung Transplant 4/12/05
[Medscape Medical News]
Preliminary experience suggests success in end-stage lung failure patients with ventilation-refractory hypercapnia.
Ventricular Support Reduces Pediatric Heart Disease Deaths 4/11/05
[Medscape Medical News]
In a multicenter, prospective database study, most children were successfully bridged to transplant with a ventricular assist device.
Inhaled Immunosuppressant Cuts Death Risk After Lung Transplant 4/11/05
[Medscape Medical News]
The "breakthrough" therapy could address an unmet need, researchers suggest.
Tacrolimus/MMF Safe, More Effective in Cardiac Transplant 4/8/05
[Medscape Medical News]
Final study results show fewer rejections and adverse effects compared with other common regimens.
Registry for Circulatory Support Devices Shows 50% Survival at 12 Months 4/8/05
[Medscape Medical News]
A device database, now 3 years old, sheds new light on posttransplant survival and complications, and the differential benefit by age.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and were developed in collaboration with the International Society for Heart and Lung Transplantation.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2005 Medscape.

 


WebMD

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.